Promising new combo aims to improve leukemia treatment
NCT ID NCT06773936
First seen Jan 11, 2026 · Last updated May 07, 2026 · Updated 15 times
Summary
This study tests whether adding the drug asciminib to usual treatment (dasatinib, prednisone, and blinatumomab) works better for people newly diagnosed with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). About 55 adults will take part. The main goal is to see if the cancer's genetic marker drops to very low levels by day 85.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baptist Memorial Health Care
Memphis, Tennessee, 38120, United States
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Northwell Health/Center for Advanced Medicine
Lake Success, New York, 11042, United States
-
UC Irvine Medical Center
Orange, California, 92868, United States
-
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
-
University of Cincinnati Cancer Ctr-UC Medical Ctr
Cincinnati, Ohio, 45267, United States
-
University of Rochester Medical Center
Rochester, New York, 14642, United States
Conditions
Explore the condition pages connected to this study.